About 5,230,000 results
Any time 
Open links in new tab
Pfizer withdraws sickle cell drug Oxbryta
✕About this result- This title and these news articles are related to your search term(s).
- Articles come from a variety of sources across the web.
- Titles are algorithmically generated based on content related to your search term(s).
- People also ask
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease …
WEB6 days ago · NEW YORK-- (BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of …
Pfizer withdraws Oxbryta from global markets, cites safety concerns
WEB17 hours ago · Pfizer has voluntarily withdrawn Oxbryta (voxelotor), a conditionally approved oral therapy for sickle cell disease (SCD), from worldwide markets, saying …
FDA is alerting patients and health care professionals about the ...
WEB5 days ago · Pfizer Inc., the manufacturer of Oxbryta, announced it is voluntarily withdrawing the medication from the market, ceasing distribution, and discontinuing all …
Searches you might like
MARAC Statement: Pfizer’s Voxelotor (Oxbryta®) …
WEB4 days ago · What is the news? Pfizer announced the withdrawal of voxelotor (Oxbryta®) from national and global markets on September 25, 2024. Clinical research was also stopped.
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease …
WEBPfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all …
Pfizer decision to withdrawal sickle cell drug leaves …
WEB6 days ago · The move underscored the severity of the risks recently seen in studies of the drug, Oxbryta, in which researchers have reported a number of deaths among patients who were receiving it.
Pfizer pulls sickle cell disease therapy Oxbryta from markets
WEB6 days ago · Pfizer will voluntarily pull its sickle cell disease (SCD) drug Oxbryta from all markets worldwide, a major blow to a $5.4 billion acquisition the New York pharma …
Pfizer withdraws sickle-cell disease treatment | Reuters
WEB6 days ago · Sept 26 (Reuters) - U.S. drugmaker Pfizer (PFE.N) said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is …
Pfizer withdraws sickle cell treatment due to safety …
WEB5 days ago · Pfizer has voluntarily withdrawn its sickle cell disease treatment Oxbryta (voxelotor) from the market due to safety concerns. The Food and Drug Administration (FDA) recommends clinicians stop …
EMA recommends suspension of sickle cell disease medicine Oxbryta
WEB6 days ago · EMA’s human medicines committee (CHMP) has recommended suspending the marketing authorisation for the sickle cell disease medicine Oxbryta (voxelotor); this …
